Search research articles
Contact Us
Filters
Showing results (111-120 of 277) with videos related to
Page
of 28
Sort By:
Neurology
|
November 27, 2019
Qualitative study on the price of drugs for multiple sclerosis: Gaming the system
Daniel M Hartung, Lindsey Alley, Kirbee A Johnston, et al.
Annales De Genetique
|
March 1, 1971
[46,XY-45,X mosaicism and 18p- deletion]
F Giraud, M Hartung, J F Mattei, et al.
Clinical Therapeutics
|
December 4, 2014
Changes in long-acting β-agonist utilization after the FDA's 2010 drug safety communication
Daniel M Hartung, Luke Middleton, Sheila Markwardt, et al.
Proteomics
|
September 3, 2020
Combined Targeted Proteomics and Oxylipin Metabolomics for Monitoring of the COX-2 Pathway
Nicole M Hartung, Annika I Ostermann, Stephan Immenschuh, et al.
Journal of Abnormal Psychology
|
November 14, 2002
Understanding the relations among gender, disinhibition, and disruptive behavior in adolescents
Cynthia M Hartung, Richard Milich, Donald R Lynam, et al.
Annals of Internal Medicine
|
October 15, 2019
Older Drugs With Limited Trial Evidence: Are They Worth the Expense?
Daniel M Hartung, David M Cohen, Atul Deodhar, et al.
Journal of Attention Disorders
|
October 25, 2021
Networks of ADHD and SCT Symptoms in Emerging Adulthood
Christine A Lee, Patrick K Goh, Christopher R Shelton, et al.
International Journal of MS Care
|
April 25, 2022
Characteristics of Prescription Drug Use Among Individuals With Multiple Sclerosis in the US Medicare Population
Daniel M Hartung, Kirbee A Johnston, Jessina C McGregor, et al.
Archives of Sexual Behavior
|
June 1, 1972
Translation. XO-XY mosaics: six case studies
F Giraud, M Hartung, Y Brusquet, et al.
BMC Family Practice
|
January 2, 2013
A pilot study evaluating alternative approaches of academic detailing in rural family practice clinics
Daniel M Hartung, Ann Hamer, Luke Middleton, et al.
Page
of 28
Search research articles
Search
Showing results (111-120 of 277) with videos related to
Sort By:
Page
of 28
Neurology
|
November 27, 2019
Qualitative study on the price of drugs for multiple sclerosis: Gaming the system
Daniel M Hartung, Lindsey Alley, Kirbee A Johnston, et al.
Annales De Genetique
|
March 1, 1971
[46,XY-45,X mosaicism and 18p- deletion]
F Giraud, M Hartung, J F Mattei, et al.
Clinical Therapeutics
|
December 4, 2014
Changes in long-acting β-agonist utilization after the FDA's 2010 drug safety communication
Daniel M Hartung, Luke Middleton, Sheila Markwardt, et al.
Proteomics
|
September 3, 2020
Combined Targeted Proteomics and Oxylipin Metabolomics for Monitoring of the COX-2 Pathway
Nicole M Hartung, Annika I Ostermann, Stephan Immenschuh, et al.
Journal of Abnormal Psychology
|
November 14, 2002
Understanding the relations among gender, disinhibition, and disruptive behavior in adolescents
Cynthia M Hartung, Richard Milich, Donald R Lynam, et al.
Annals of Internal Medicine
|
October 15, 2019
Older Drugs With Limited Trial Evidence: Are They Worth the Expense?
Daniel M Hartung, David M Cohen, Atul Deodhar, et al.
Journal of Attention Disorders
|
October 25, 2021
Networks of ADHD and SCT Symptoms in Emerging Adulthood
Christine A Lee, Patrick K Goh, Christopher R Shelton, et al.
International Journal of MS Care
|
April 25, 2022
Characteristics of Prescription Drug Use Among Individuals With Multiple Sclerosis in the US Medicare Population
Daniel M Hartung, Kirbee A Johnston, Jessina C McGregor, et al.
Archives of Sexual Behavior
|
June 1, 1972
Translation. XO-XY mosaics: six case studies
F Giraud, M Hartung, Y Brusquet, et al.
BMC Family Practice
|
January 2, 2013
A pilot study evaluating alternative approaches of academic detailing in rural family practice clinics
Daniel M Hartung, Ann Hamer, Luke Middleton, et al.
Page
of 28